Gyno-Pevaryl (Econazole Nitrate)

Gyno‑Pevaryl is indicated for the treatment of fungal infections of the vagina.

• Management of acute vulvovaginal candidiasis caused by susceptible Candida species.
• Treatment of recurrent vulvovaginal yeast infections when prescribed by a healthcare professional.
• Adjunct therapy for mixed bacterial‑fungal vaginal infections, as directed.
• Use in patients who require a topical antifungal with minimal systemic absorption.
• Application in clinical situations where a non‑systemic option is preferred.
• Supportive care for symptomatic relief of itching and discharge associated with candidal infection.

Potential adverse effects of Gyno‑Pevaryl are generally limited to local reactions, though systemic effects are rare and usually associated with extensive mucosal absorption.

Common

• Mild vaginal irritation or burning sensation.
• Itching or pruritus at the application site.
• Vaginal discharge that is watery or slightly colored.
• Temporary discomfort during intercourse.
• Redness or erythema of the vulvar tissue.
• Unusual odor from vaginal discharge.
• Dryness of the vaginal mucosa.

Serious

• Severe allergic reaction such as swelling of the lips, tongue, or face.
• Persistent or worsening vaginal symptoms indicating secondary infection.
• Signs of systemic toxicity such as fever, chills, or malaise.
• Development of secondary bacterial infection requiring medical evaluation.

Before using Gyno‑Pevaryl, certain precautions should be considered to ensure safe and effective therapy.

• Confirm diagnosis of vulvovaginal candidiasis with a healthcare professional before initiating treatment.
• Avoid use if known hypersensitivity to econazole nitrate or any imidazole antifungal exists.
• Do not apply the product to inflamed, ulcerated, or broken mucosal tissue.
• Discuss use during pregnancy or breastfeeding with a clinician, as safety data are limited.
• Keep the product out of reach of children and store according to label instructions.
• Report any persistent irritation, rash, or worsening symptoms to a medical provider promptly.

Gyno‑Pevaryl may interact with other topical or systemic agents; awareness of potential interactions helps prevent reduced efficacy or increased toxicity.

Avoid

• Concurrent use of other vaginal antifungal preparations containing azole agents, which can increase local irritation.
• Application of spermicidal or lubricating products containing non‑oxynol‑9 immediately before or after Gyno‑Pevaryl.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) may increase overall azole exposure; coordinate therapy with a prescriber.
• Hormonal contraceptives administered vaginally; monitor for any change in effectiveness.
• Use with intravaginal antibiotics; assess for possible alteration of vaginal flora.